Electrical Impedance Myography
Electrical Impedance Myography is a medical device with 7 clinical trials. Currently 4 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
4
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
EIM Via the Myolex mScan as an ALS Biomarker
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
Muscle Health Measurements Using Electrical Impedance Myography
Evaluation of a Novel Class of Objective Myofascial Pain Assessments
Application of Electrical Impedance Myography (EIM) as a Potential Biomarker of Idiopathic Inflammatory Myopathies
Clinical Trials (7)
EIM Via the Myolex mScan as an ALS Biomarker
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
Muscle Health Measurements Using Electrical Impedance Myography
Evaluation of a Novel Class of Objective Myofascial Pain Assessments
Application of Electrical Impedance Myography (EIM) as a Potential Biomarker of Idiopathic Inflammatory Myopathies
Pompe Disease QMUS and EIM
Accurate Screening Tools for Dysphagia in Amyotrophic Lateral Sclerosis (ALS)
All 7 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 7